Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Neuromuscul Disord ; 23(12): 962-8, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24120572

ABSTRACT

A recent study has shown that 36 persons who had recovered from juvenile dermatomyositis (JDM) have on average an 18% decrease in maximal oxygen uptake. The objective of this study was to investigate the effect of a 12-week aerobic training program in this group, and assess whether aerobic training can normalize aerobic capacity to the expected level for age and gender. The patients participating in the study, one male and nine females (16-42 years of age), were in remission from JDM, defined as no clinical or biochemical evidence of disease activity and no medical treatment for 1 year. The patients had a median disease duration of 3.4 years (1.4-10.3), a median treatment duration of 2.4 years (0.4-9.3) and a median duration of remission of 7.0 years (1.2-30.0). Patients trained at home on a cycle ergometer for 12 weeks at a heart rate interval corresponding to 65% of their maximal oxygen uptake (VO(2max)). VO(2max) and maximal workload (W(max)) were determined before and after the 12-week training period through an incremental cycling test to exhaustion. The patients served as their own controls. Eight patients with JDM in remission completed the 12-week exercise program; one patient completed 9 weeks out of the 12-week program and one dropped out of the study. Training increased VO(2max) and W(max) by 26% and 30% (P < 0.001). Creatine kinase (CK) levels were normal pre-training and did not change with training, reflecting no muscle damage. We also found that at a given workload, heart rate was lowered significantly after the 12-week training period, indicating an improvement in cardiovascular fitness. This study shows that 12 weeks of moderate-intensity aerobic training is an effective and safe method to increase oxidative capacity and fitness in persons who have recovered from JDM. The results indicate that the low oxidative capacity in JDM patients in remission is reversible and can be improved. Thus, we recommend frequent aerobic training to be incorporated into supervised physiotherapy sessions in the treatment of JDM patients in remission.


Subject(s)
Dermatomyositis/rehabilitation , Exercise Therapy/methods , Exercise/physiology , Recovery of Function , Absorptiometry, Photon , Activities of Daily Living , Adolescent , Adult , Body Composition , Dermatomyositis/physiopathology , Dermatomyositis/psychology , Female , Heart Rate/physiology , Humans , Male , Middle Aged , Motor Activity , Muscle Strength , Oxygen Consumption , Patient Compliance , Young Adult
2.
Neuromuscul Disord ; 23(7): 562-7, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23746544

ABSTRACT

Defects in glycosylations of α-dystroglycan are associated with mutations in several genes, including the fukutin gene (FKTN). Hypoglycosylation of α-dystroglycan results in several forms of muscular dystrophy with variable phenotype. Outside Japan, the prevalence of muscular dystrophies related to aberrations of FKTN is rare, with only eight reported cases of limb girdle phenotype (LGMD2M). We describe the mildest affected patient outside Japan with genetically confirmed LGMD2M and onset of symptoms at age 14. She was brought to medical attention at age 12, not because of muscle weakness, but due to episodes of tachycardia caused by Wolff-Parkinson-White syndrome. On examination, she had rigid spine syndrome, a typical limb girdle dystrophy pattern of muscle weakness, cardiomyopathy, and serum CK levels >2000 IU/L (normal <150 IU/L). A homozygous, novel c.917A>G; p.Y306C mutation in the FKTN gene was found. The case confirms FKTN mutations as a cause of LGMD2M without mental retardation and expands the phenotypic spectrum for LGMD2M to include cardiomyopathy and rigid spine syndrome in the mildest affected non-Japanese patient reported so far.


Subject(s)
Membrane Proteins/genetics , Muscular Dystrophies, Limb-Girdle/genetics , Mutation/genetics , Age of Onset , Dystroglycans/genetics , Dystroglycans/metabolism , Female , Genotype , Humans , Japan , Mallory Bodies/pathology , Muscle Weakness/genetics , Muscle Weakness/metabolism , Muscular Dystrophies/complications , Muscular Dystrophies/diagnosis , Muscular Dystrophies, Limb-Girdle/complications , Muscular Dystrophies, Limb-Girdle/diagnosis , Phenotype , Scoliosis/complications , Scoliosis/diagnosis , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...